Expansion of thyroid surgical territory through 10,000 cases under the da Vinci robotic knife
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Robotic transaxillary thyroid surgery (RTTS) is safe and effective, with expanding indications. This study of 10,000 cases shows its feasibility for thyroid cancer and benign conditions, with low recurrence rates.
Area Of Science
- Minimally Invasive Surgery
- Surgical Oncology
- Endocrine Surgery
Background
- Robotic transaxillary thyroid surgery (RTTS) has evolved, broadening its applicability.
- Experience with RTTS has grown significantly, necessitating an analysis of outcomes and indications.
Purpose Of The Study
- To report outcomes and insights from 10,000 robotic transaxillary thyroid surgery cases.
- To document the expansion of indications for RTTS over time.
Main Methods
- A retrospective review of 10,000 RTTS procedures performed between October 2007 and April 2023.
- Analysis of patient demographics, diagnoses (thyroid cancer, benign nodules, Graves' disease), surgical systems used (da Vinci S, Si, Xi, SP), and postoperative complications.
Main Results
- 94.0% of patients had thyroid cancer; 5.4% had benign conditions.
- Transient hypoparathyroidism was the most common complication (37.91%); recurrence occurred in 1.1% of thyroid cancer patients.
- RTTS was safely performed in 53 patients with large nodules (≥5 cm), previously excluded from indications.
Conclusions
- Robotic transaxillary thyroid surgery demonstrates safety and feasibility from both surgical and oncological viewpoints.
- The range of suitable indications for RTTS is progressively expanding, including larger nodules.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.